Get to Know 24Genetics: Integrating Genetics and Artificial Intelligence for better Health and Wellbeing

Hosted by Capital Cell, Naira França & Mariona Vidal Picamoles
Zoom
Registration
Past Event
Welcome! To join the event, please register below.
About Event

Get to Know 24Genetics: Integrating Genetics and Artificial Intelligence for better Health and Wellbeing

24Genetics integrates genetics and artificial intelligence to provide subscription-based personalized health insights. Their services focus on DNA-based solutions in nutrition, fitness, skincare, and preventive health.

Since 2021, the company has tripled its turnover and now serves customers in over 100 countries. It has distributors on five continents and collaborates with hospital groups and analytical laboratories, including Eurofins, one of Europe’s largest. B2B agreements now contribute 33% of its revenue.

This session is designed for doctors, investors, and healthcare enthusiasts, interested in learning how 24Genetics applies AI to improve precision, streamline processes, and scale their genetic services efficiently.

Explore the details here: https://capitalcell.com/en/campaign/24genetics/

What will we cover in these sessions?

  • What is 24Genetics?

Discover the team behind 24Genetics, their mission, current progress, and future plans.

  • Why is this project so relevant?

Francisco Rey is a leader in global finance and investment, with a distinguished career at top institutions. He spent over 13 years at Merrill Lynch in New York and London, was a Partner and Senior Managing Director at The Blackstone Group, and led BBVA’s Investment Banking division, overseeing major strategic operations. Currently, he is the Executive Chairman of Credit Suisse Europe Bank, part of UBS Group, and has served on the board of Wells Fargo Securities International.

In addition to his banking career, Francisco has driven successful startup exits, including Waylet (acquired by Repsol) and Privalia (acquired by Amazon).

As the lead investor for 24Genetics, he will provide his perspective on the potential of 24Genetics to address key challenges in the market.

  • Q&A Session

Get answers to your questions about Capital Cell, how it works, and how you can be part of this journey.

Spread the Word

Share this webinar with your network to help advance the future of tissue transplants. See you soon!